Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 1.0 Contact Hour.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Oncology Briefings™: How Can Nurses Make the Biggest Impact in Melanoma Treatment and Management?

Release Date: May 31, 2019
Expiration Date: May 31, 2020
Media: Internet - based

Activity Overview

This continuing medical education (CME)-certified online activity, “Oncology Briefings™: How Can Nurses Make the Biggest Impact in Melanoma Treatment and Management?” developed in Physicians’ Education Resource®, LLC, established Oncology Briefings™ legacy format, is an online interactive monograph that provides an overview of the treatment options available for melanoma and the role of the advanced practice nurse in managing care for patients with melanoma. Krista M. Rubin, MS, FNP-BC, discusses current and emerging treatment options for the treatment of melanoma, emphasizes the keys to managing adverse events, and provides strategies for counseling patients to optimize adherence and patient outcomes.

Benefits of Participating

  • Learn about the current and emerging treatment options for adjuvant therapy and systemic treatment options for metastatic melanoma.
  • Benefit from the expertise of an experienced advanced practice nurse in managing care for patients with melanoma during treatment with targeted therapy and immunotherapy.
  • Learn about key strategies for counseling patients on managing adverse events and identifying appropriate options for clinical trial participation.

CME Activity Table of Contents

  • Pretest
  • Activity
  • Posttest, Evaluation, and Request for Credit

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME/CE certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward advanced practitioners and nurses who treat patients with melanoma. Medical oncologists, fellows, pharmacists, researchers, and other healthcare professionals interested in the treatment of melanoma are invited to participate.

Learning Objectives

Upon successful completion of this educational program, you should be better prepared to:

  • Outline the mechanistic rationale and clinical profiles among BRAF/MEK inhibitors and immunotherapeutic strategies which are utilized in melanoma management.
  • Apply best practices to proactively identify and mitigate the impact of treatment-related toxicities in settings where patients with melanoma are managed.
  • Evaluate nursing strategies to optimize counseling among patients with melanoma to ensure adherence and proactive identification and management of treatment-related toxicities.

Faculty, Staff, and Planners’ Disclosures

Krista M. Rubin
Krista M. Rubin, MS, FNP-BC
Nurse Practitioner, Center for Melanoma
Massachusetts General Hospital Cancer Center
Boston, MA

Disclosures: Consultant: Bristol-Myers Squibb, Merck

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only; it is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By